Lyall, A E
Pasternak, O
Robinson, D G
Newell, D
Trampush, J W
Gallego, J A
Fava, M
Malhotra, A K
Karlsgodt, K H
Kubicki, M
Szeszko, P R
Article History
Received: 19 February 2016
Revised: 11 January 2017
Accepted: 17 January 2017
First Online: 28 March 2017
Competing interests
: For a complete list of Dr. Fava’s disclosures, please seeExternalRef removed. Dr. Malhotra has been a consultant for Genomind, Forum Pharmaceuticals and Takeda Pharmaceuticals. The other authors declare no conflict of interest.